The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigating the association between peak post-infusion absolute lymphocyte count (ALC) and delayed toxicity in myeloma (MM) patients (pts) receiving cilta-cel.
 
Kenneth Lim
Research Funding - Sanofi (Inst)
 
Ricardo Parrondo
Consulting or Advisory Role - AstraZeneca; Sanofi Aventis GmbH
Research Funding - Bristol Myers Squibb Foundation; GlaxoSmithKline
Expert Testimony - MJH Life Sciences
 
Saurabh Chhabra
No Relationships to Disclose
 
Katharine Dooley
No Relationships to Disclose
 
Andre De Menezes Silva Corraes
No Relationships to Disclose
 
Morie Gertz
Honoraria - Abbvie; Akcea Therapeutics; Alnylam; Amgen; Apellis Pharmaceuticals; Celgene; Janssen Oncology; Juno/Celgene; Med Learning Group; Prothena; Research to Practice; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi; Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena
 
Lisa Hwa
No Relationships to Disclose
 
Haily Stephens
No Relationships to Disclose
 
Prashant Kapoor
Honoraria - Abbvie (Inst); Abbvie (Inst); AstraZeneca; BeiGene; MustangBio; Pharmacyclics; Sanofi (Inst)
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Ichnos Sciences (Inst); Karyopharm Therapeutics (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Sanofi
 
Melinda Tan
No Relationships to Disclose
 
Taxiarchis Kourelis
Research Funding - Novartis; Pfizer (Inst)
 
Rahma Warsame
Consulting or Advisory Role - Sanofi
 
Joselle Cook
Stock and Other Ownership Interests - Geron
 
Moritz Binder
No Relationships to Disclose
 
Peter Bergsagel
Consulting or Advisory Role - Abbvie; CellCentric; Omeros; Pfizer
Research Funding - Celgene; Pfizer (I); Sanofi
Patents, Royalties, Other Intellectual Property - Mouse model of multiple myeloma
 
Susan Geyer
No Relationships to Disclose
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Beigene; Janssen; Pfizer
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen (Inst); Beigene; BMS (Inst); Cellectar (Inst); GlaxoSmithKline; Janssen (Inst); Pharmacyclics (Inst); Regeneron; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Ascentage Pharma (Inst); BMS (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); Pharmacyclics (Inst); Sanofi (Inst)
 
Rafael Fonseca
Leadership - Antagene
Stock and Other Ownership Interests - Adaptive Biotechnologies; Caris Life Sciences; OncoMyx Therapeutics
Honoraria - Abbvie; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead Company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead Company; Merck Sharp & Dohme; Oncopeptides; OncoTracker; Pfizer; Pharmacyclics; RA Capital; Regeneron; Sanofi; Takeda
Travel, Accommodations, Expenses - Celgene
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tessera (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)